
Moluzaq contains Molnupiravir 200mg, an oral antiviral medicine developed to treat mild to moderate COVID-19 in adults at risk of developing severe illness.
| Generic Name | Molnupiravir |
| Manufacturer | Astraea Life Sciences Pvt Ltd |
| Packing | 40 Capsules |
| Prescribed For | (COVID-19) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




The typical dosage is 800 mg per day (i.e., 200mg taken four times a day) for 5 days, or as prescribed by your doctor. Swallow the tablet whole with water. Do not crush or chew it.
Yes, a valid prescription from a registered medical practitioner is mandatory before purchasing Molnupiravir (Lagevrio).
Moluzaq does not cure COVID-19 but helps reduce the viral load, shorten the duration of illness, and lowers the risk of hospitalization in high-risk individuals.
No. Moluzaq is not advised during pregnancy or breastfeeding due to potential risks to the baby. Women of childbearing age should use contraception during and after the treatment.
You can place an order for Moluzaq Molnupiravir Capsule 200mg at a discounted price directly from our licensed international super-specialty pharmacy, or by contacting us via WhatsApp, phone, email, or live chat. Our team will assist you promptly with the ordering process.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.